Breckenridge recalls propranolol lot over possible metal fragments
Breckenridge Pharmaceutical is recalling one lot of 60 mg propranolol extended-release capsules distributed nationwide after the company said the capsules may contain metal fragments that could injure tissue in the digestive tract. The voluntary consumer-level recall covers lot PK25110035, shipped to wholesalers and pharmacies from October 26 through November 4, 2026.
The recalled product is Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, packaged in 100-count bottles. The lot has a May 2029 expiration date and National Drug Code 51991-817-01. The capsules were manufactured by Adare Pharma Solutions, according to the recall information.
Breckenridge said fragments could cause cuts in the mouth, esophagus, stomach or intestine. The company said it is not aware of adverse events assessed as related to the recall. The reports repeat the company’s account; they do not provide independent test results confirming contamination in the recalled lot or injury records.
Breckenridge said the recalled lot used the same intermediate material as a different lot in which metal contamination was detected. That other lot was not released to the market. The company has not said in...